NM_001430.5:c.218-3632G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001430.5(EPAS1):c.218-3632G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.227 in 152,006 control chromosomes in the GnomAD database, including 4,222 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.23 ( 4222 hom., cov: 32)
Consequence
EPAS1
NM_001430.5 intron
NM_001430.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.80
Publications
4 publications found
Genes affected
EPAS1 (HGNC:3374): (endothelial PAS domain protein 1) This gene encodes a transcription factor involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels. Mutations in this gene are associated with erythrocytosis familial type 4. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.301 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EPAS1 | ENST00000263734.5 | c.218-3632G>A | intron_variant | Intron 2 of 15 | 1 | NM_001430.5 | ENSP00000263734.3 | |||
| EPAS1 | ENST00000449347.5 | c.218-3632G>A | intron_variant | Intron 3 of 6 | 3 | ENSP00000406137.1 | ||||
| EPAS1 | ENST00000475822.1 | n.409-3632G>A | intron_variant | Intron 2 of 2 | 4 | |||||
| LINC01820 | ENST00000843948.1 | n.103-4460C>T | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.227 AC: 34478AN: 151888Hom.: 4219 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
34478
AN:
151888
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.227 AC: 34497AN: 152006Hom.: 4222 Cov.: 32 AF XY: 0.231 AC XY: 17145AN XY: 74322 show subpopulations
GnomAD4 genome
AF:
AC:
34497
AN:
152006
Hom.:
Cov.:
32
AF XY:
AC XY:
17145
AN XY:
74322
show subpopulations
African (AFR)
AF:
AC:
8225
AN:
41460
American (AMR)
AF:
AC:
4709
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
1142
AN:
3470
East Asian (EAS)
AF:
AC:
516
AN:
5172
South Asian (SAS)
AF:
AC:
1410
AN:
4812
European-Finnish (FIN)
AF:
AC:
2583
AN:
10566
Middle Eastern (MID)
AF:
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15181
AN:
67950
Other (OTH)
AF:
AC:
490
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1365
2731
4096
5462
6827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
661
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.